| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |